These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 37541532)

  • 1. Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu.
    Wang R; Hu Q; Wu Y; Guan N; Han X; Guan X
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188962. PubMed ID: 37541532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
    Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
    Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting metabolism to enhance immunotherapy within tumor microenvironment.
    Liang XH; Chen XY; Yan Y; Cheng AY; Lin JY; Jiang YX; Chen HZ; Jin JM; Luan X
    Acta Pharmacol Sin; 2024 Oct; 45(10):2011-2022. PubMed ID: 38811773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications.
    Liu Y; Zhao Y; Song H; Li Y; Liu Z; Ye Z; Zhao J; Wu Y; Tang J; Yao M
    Cancer Lett; 2024 Aug; 597():217076. PubMed ID: 38906524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lipid metabolic reprogramming in tumor microenvironment.
    Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
    Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty Acid Metabolism and Cancer Immunotherapy.
    Luo Y; Wang H; Liu B; Wei J
    Curr Oncol Rep; 2022 May; 24(5):659-670. PubMed ID: 35230593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
    Zhang M; Wei T; Zhang X; Guo D
    Front Immunol; 2022; 13():937406. PubMed ID: 36131916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.
    Hu B; Lin JZ; Yang XB; Sang XT
    Cell Prolif; 2020 Mar; 53(3):e12772. PubMed ID: 32003505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
    Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
    Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of fatty acid metabolism in tumourigenesis: Beyond providing nutrition (Review).
    Yu XH; Ren XH; Liang XH; Tang YL
    Mol Med Rep; 2018 Dec; 18(6):5307-5316. PubMed ID: 30365095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
    Li L; Ma SR; Yu ZL
    Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment.
    Yu W; Lei Q; Yang L; Qin G; Liu S; Wang D; Ping Y; Zhang Y
    J Hematol Oncol; 2021 Nov; 14(1):187. PubMed ID: 34742349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Aspects of Cancer Cell Metabolism.
    Ucche S; Hayakawa Y
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad.
    Bleve A; Durante B; Sica A; Consonni FM
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy.
    Lim SA
    BMB Rep; 2024 Sep; 57(9):388-399. PubMed ID: 38919017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cancer metabolic reprogramming and immune response.
    Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
    Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic interventions: A new insight into the cancer immunotherapy.
    Yu T; Dong T; Eyvani H; Fang Y; Wang X; Zhang X; Lu X
    Arch Biochem Biophys; 2021 Jan; 697():108659. PubMed ID: 33144083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles of fatty acid metabolism in cancer and their targeted drug development.
    An Q; Lin R; Wang D; Wang C
    Eur J Med Chem; 2022 Oct; 240():114613. PubMed ID: 35853429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer.
    Shang Z; Ma Z; Wu E; Chen X; Tuo B; Li T; Liu X
    Biomed Pharmacother; 2024 Jan; 170():116030. PubMed ID: 38128177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research Progress and New Immunotherapy Strategies of Tumor Microenvironment Metabolism].
    Peng YM; Luo XM; Chen JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):505-509. PubMed ID: 37248575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.